Company

Stories

OUR STORY

  • The dream of safer disease treatment with 'third medicine, electroceuticals’

    Entwick is a growing company specializing innon-invasive electroceutical therapies. Non-invasive electroceutical therapies are electronic medical devices that aim to treat diseases through various physical and optical external stimuli, and is attracting attention as a 'third new medicine' because it has the advantage of treating without chemical side effects compared to general medicines.

    Entwick is a research-oriented venture that applies engineering technology to medical and therapeutic technologies to develop more effective, non-invasive electroceuticals. Entwick is focusing on the development of safe and highly effective personalized chronic disease electroceutical treatments for the aging population and is commercializing them for arthritis, hair loss, and deep vein thrombosis.

  • 'ArthronPulse', an electroceutical to treat arthritis that goes beyond pharmaceuticals

    Entwick's first electrotherapeutic treatment is ArtheonPluse, an electroceutical for degenerative arthritis that utilizes ELF-EMF and LLL treatment technologies. Many studies have reported that ELF-EMF inhibits the expression of pro-arthritic factors and increases cartilage matrix-enhancing factors, while LLL improves joint pain.

    ArtheonPulse, Entwick’s electroceutical for treating arthritis, is a cordless, wearable form of low-power, far-field magnetic transfer technology and three-wavelength, low-level laser therapy. It is a medical homecare product with a form factor for mobility that enables low-cost, consistent joint care.

  • A dream of the last cure
    that maximized the body's ability to heal.

    Despite advances in medicine and medical technology, we still struggle with many incurable diseases for which we don't know the exact cause or cure. People suffering from incurable diseases who have been told by their doctors that there is nothing more that can be done. Our dream is to create a cure that will give every patient in the world and their families a last, but not least, treatment.